atopic-dermatitis

Documents about atopic-dermatitis

• A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis#804287ClinicalTrials.gov
• Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis#864693ClinicalTrials.gov
• Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks#875841ClinicalTrials.gov
• Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema#917008ClinicalTrials.gov
• Investigation of Efficacy and Safety of EPOGAM#875072ClinicalTrials.gov
• Defining the Potential for Disease Modification in Atopic Dermatitis.#988269NCBI PubMed Central
• Platelet Activation in Chronic Inflammatory Skin Diseases#993191ClinicalTrials.gov
• Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema#882007ClinicalTrials.gov
• A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated#982095ClinicalTrials.gov
• The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants#967561ClinicalTrials.gov
• Real-Life Performance of the Dermatology Long-Term Life Impact Measure (DLLIM) in Atopic Dermatitis: An International Study of 15,450 Patients#818554HAL (France)
• Dietary Intervention on Atopy#801362ClinicalTrials.gov
• Methodological Study of the Effect of a Lotion Containing Nature Based Microbial Extract on Atopic Skin#846103ClinicalTrials.gov
• Association between serum platelet level and dermatitis rash: Results from the China Health and Nutrition Survey#152685PLOS
• Artificial intelligence in atopic dermatitis: Current applications and future perspectives.#154329NCBI PubMed Central
• Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants#325159ClinicalTrials.gov
• Comments on Dermatologists' TikTok Videos on Atopic Dermatitis: Content Analysis.#380975NCBI PubMed Central
• Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis#837808ClinicalTrials.gov
• Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)#851263ClinicalTrials.gov
• Opzelura Experience Study#843389ClinicalTrials.gov
• First in Human of Single and Multiple Doses of MOR106#894332ClinicalTrials.gov
• Dupilumab en el tratamiento de pacientes pediátricos con dermatitis atópica moderada a severa en Chile. Serie de 10 casos clínicos#483700Repositorio Universidad del Desarrollo
• To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin#848146ClinicalTrials.gov
• Rol educativo en enfermería en la prevención de la dermatitis en niños preescolares#658253DIALNET OAI Articles
• Mediation of pediatric atopic dermatitis in emotional and behavioral outcomes by sleep disturbance.#244198NCBI PubMed Central
• Pediatric atopic dermatitis: biomarker advances in severity, persistence, and non-invasive monitoring.#636364NCBI PubMed Central
• Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects#911437ClinicalTrials.gov
• Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND#144942HAL (France)
• A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable#869752ClinicalTrials.gov
• Feasibility and Acceptability of Patient-Reported Outcomes Collection in Routine Pediatric Atopic Dermatitis Care.#244200NCBI PubMed Central
• Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course Impairment.#292160NCBI PubMed Central
• Editorial: Rethinking infection in pediatric atopic dermatitis: from microbial dysbiosis to precision prevention.#354615NCBI PubMed Central
• Mechanisms and Research Advances in Drug Delivery Systems for Psoriasis and Atopic Dermatitis.#368035NCBI PubMed Central
• Age differences in psychological comorbidity in atopic dermatitis: a systematic review and meta-analysis.#392656NCBI PubMed Central
• Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation#831028ClinicalTrials.gov
• Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index#842126ClinicalTrials.gov
• Efficacy of Topical Cannabidiol for Eczema#877083ClinicalTrials.gov
• A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD#1033097ClinicalTrials.gov
• Long-term benefits of upadacitinib for Atopic Dermatitis: deep responses in patient-reported outcomes over 140 weeks from the Measure Up 1 and Measure Up 2 clinical trials.#174817PubMed
• Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis#979109ClinicalTrials.gov
• Current research landscape and future prospects of in silico modeling approaches for atopic dermatitis.#469153NCBI PubMed Central
• Therapeutic Modulation of Dupilumab in Patients with Severe Atopic Dermatitis: Clinical Effectiveness in Real Life#625563IRIS
• Blue Light in the Treatment of Inflammatory Skin Diseases#841299ClinicalTrials.gov
• Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%#880089ClinicalTrials.gov
• Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism#980432ClinicalTrials.gov
• A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis#915523ClinicalTrials.gov
• A Study of Atopic Dermatitis in Elementary School Children in Hirosaki City, Aomori Prefecture, Japan#384171CiNii
• Divergent immunometabolic reprogramming in psoriasis and atopic dermatitis: a tale of two inflammatory skin diseases.#418318NCBI PubMed Central
• Factors Influencing Self-Management Behaviors in Patients with Atopic Dermatitis and Intervention Strategies: A Narrative Review.#458522NCBI PubMed Central
• Prenatal PM(2.5) exposure drives epigenetic reprogramming of fetal macrophages linked to atopic dermatitis.#671257NCBI PubMed Central